SCOTTSDALE, Ariz., July 20, 2022 /PRNewswire/ -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTC:EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA-cleared WellnessPro®, designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, today announces a significant restructuring of its balance sheet via an agreement with a major debtholder to convert 100% of promissory notes owed and currently subject to deferment into restricted, unregistered common shares of the Company.
Read more at prnewswire.comElectromedical Technologies Announces Significant Debt Reduction through Restructuring and Conversion into Restricted Common Shares of the Company
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
